Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

Pricing
Back to Stakeholders
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchUniversities and Colleges with Dedicated Psychedelic Research Groups
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & Manufacturing

Queen's University

Canada
5 Trials

The Centre for Psychedelics Health and Research, a joint project with Providence Care, aims to address fundamental questions regarding psychedelics in healthcare and expand clinical understanding of psychedelic-assisted therapies.

Academic Research

0 papers

Published Papers

0

Trial Involvement

5

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
Canada
Website
Visit

Sponsored Trials

3
Not yet recruitingI, II

Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD

Start Date
October 1, 2025
Compounds
Ketamine
RecruitingII

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Start Date
May 6, 2025
Compounds
Psilocybin, Placebo
Unknown statusII

Combined Ketamine and eCBT Intervention for PTSD

Start Date
August 1, 2021
Compounds
Ketamine

Collaborated Trials

2
RecruitingI, II

Psilocybin for Psychological and Existential Distress in Palliative Care

Start Date
August 1, 2021
Compounds
Psilocybin
Temporarily not availableIII

Ketamine Versus Electroconvulsive Therapy in Depression

Start Date
October 29, 2018
Compounds
Ketamine, Placebo

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.